Ask questions in natural language or search by name, alias, or category.
20 results in Fat Loss
Semaglutide is an FDA-approved GLP-1 receptor agonist used for type 2 diabetes (Ozempic) and chronic weight management (…
Tirzepatide (Mounjaro/Zepbound) is the first FDA-approved dual GIP/GLP-1 receptor agonist, developed by Eli Lilly. It pr…
BPC-157 is a synthetic pentadecapeptide (15 amino acids) isolated from human gastric juice protein BPC. It demonstrates…
AOD-9604 is a modified fragment of human growth hormone (hGH residues 177–191) with an added N-terminal tyrosine residue…
Cagrilintide (AM833) is a long-acting amylin analogue developed by Novo Nordisk. It mimics the satiety and gastric-empty…
MOTS-c is a 16-amino-acid mitochondria-derived peptide encoded within the 12S ribosomal RNA gene of the mitochondrial ge…
Mazdutide (IBI362/OXM3) is a GLP-1/glucagon dual receptor agonist developed by Innovent Biologics (China), based on an o…
Survodutide (BI 456906) is a GLP-1/glucagon dual receptor agonist co-developed by Boehringer Ingelheim and Zealand Pharm…
5-amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT) — an enzyme highly overexpressed in…
Retatrutide (LY3437943) is an investigational triple agonist targeting GIP, GLP-1, and glucagon receptors simultaneously…
Adipotide (FTPP) is a peptidomimetic that targets prohibitin on adipocyte and endothelial cell surfaces. It induces targ…
SLU-PP-332 is a novel GLP-1 receptor agonist developed by Sichuan University. It demonstrates superior weight loss effic…
NAD+ (Nicotinamide Adenine Dinucleotide) is the central coenzyme of cellular metabolism and a critical longevity molecul…
NMN (Nicotinamide Mononucleotide) is a direct NAD+ precursor and one of the most researched longevity molecules. It is s…
LEAP2 (Liver-Expressed Antimicrobial Peptide 2) is an endogenous 40-amino acid hepatokine discovered in 2018 as the firs…
VK2735 is a late-stage investigational peptide dual GLP-1/GIP receptor agonist from Viking Therapeutics, in Phase 3 deve…
Adropin is an endogenous 43-amino acid peptide (mature form) encoded by the ENHO gene and secreted primarily by the live…
Amycretin is a Novo Nordisk investigational unimolecular peptide combining GLP-1 and amylin receptor agonism in a single…
Orforglipron (Foundayo) is an oral, non-peptide small-molecule GLP-1 receptor agonist FDA-approved in April 2026 for wei…
Pemvidutide (ALT-801) is an Altimmune investigational unimolecular peptide dual agonist of the GLP-1 and glucagon recept…